201 related articles for article (PubMed ID: 20128638)
1. Synthesis, antineoplastic and cytotoxic activities of some mononuclear Ru(II) complexes.
Thota S; Karki SS; Jayaveera KN; Balzarini J; De Clercq E
J Enzyme Inhib Med Chem; 2010 Aug; 25(4):513-9. PubMed ID: 20128638
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, anticancer, and cytotoxic activities of some mononuclear Ru(II) compounds.
Karki SS; Thota S; Darj SY; Balzarini J; De Clercq E
Bioorg Med Chem; 2007 Nov; 15(21):6632-41. PubMed ID: 17765549
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and pharmacological activities of some mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Sivakumar T
Bioorg Med Chem; 2005 Oct; 13(20):5766-73. PubMed ID: 15982893
[TBL] [Abstract][Full Text] [Related]
4. Study of ruthenium(II) complexes with anticancer drugs as ligands. Design of metal-based phototherapeutic agents.
Cini R; Tamasi G; Defazio S; Corsini M; Zanello P; Messori L; Marcon G; Piccioli F; Orioli P
Inorg Chem; 2003 Dec; 42(24):8038-52. PubMed ID: 14632524
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes.
Liu J; Zheng W; Shi S; Tan C; Chen J; Zheng K; Ji L
J Inorg Biochem; 2008 Feb; 102(2):193-202. PubMed ID: 17825915
[TBL] [Abstract][Full Text] [Related]
6. Novel ruthenium complex K2[Ru(dmgly)Cl4].2H2O is toxic to C6 astrocytoma cell line, but not to primary rat astrocytes.
Djinović V; Momcilović M; Grgurić-Sipka S; Trajković V; Mostarica Stojković M; Miljković D; Sabo T
J Inorg Biochem; 2004 Dec; 98(12):2168-73. PubMed ID: 15541507
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) carbonyl complexes containing S-methylisothiosemicarbazone based tetradentate ligand: synthesis, characterization and biological applications.
Selvamurugan S; Ramachandran R; Viswanathamurthi P
Biometals; 2013 Oct; 26(5):741-53. PubMed ID: 23780567
[TBL] [Abstract][Full Text] [Related]
8. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
[TBL] [Abstract][Full Text] [Related]
9. Thiophenolato-bridged dinuclear arene ruthenium complexes: a new family of highly cytotoxic anticancer agents.
Gras M; Therrien B; Süss-Fink G; Zava O; Dyson PJ
Dalton Trans; 2010 Nov; 39(42):10305-13. PubMed ID: 20890536
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of organometallic ruthenium(II) complexes with strong activity against several human cancer cell lines.
Morais TS; Silva TJ; Marques F; Robalo MP; Avecilla F; Amorim Madeira PJ; Mendes PJ; Santos I; Garcia MH
J Inorg Biochem; 2012 Sep; 114():65-74. PubMed ID: 22698866
[TBL] [Abstract][Full Text] [Related]
11. 1-(2-Picolyl)-substituted 1,2,3-triazole as novel chelating ligand for the preparation of ruthenium complexes with potential anticancer activity.
Bratsos I; Urankar D; Zangrando E; Genova-Kalou P; Košmrlj J; Alessio E; Turel I
Dalton Trans; 2011 May; 40(19):5188-99. PubMed ID: 21465046
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1,5-a]pyrimidine).
Velders AH; Bergamo A; Alessio E; Zangrando E; Haasnoot JG; Casarsa C; Cocchietto M; Zorzet S; Sava G
J Med Chem; 2004 Feb; 47(5):1110-21. PubMed ID: 14971891
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antitumor studies on novel Co(II), Ni(II) and Cu(II) metal complexes of bis(3-acetylcoumarin)thiocarbohydrazone.
Sathisha MP; Shetti UN; Revankar VK; Pai KS
Eur J Med Chem; 2008 Nov; 43(11):2338-46. PubMed ID: 18023933
[TBL] [Abstract][Full Text] [Related]
14. Oligonuclear polypyridylruthenium(II) complexes incorporating flexible polar and non-polar bridges: synthesis, DNA-binding and cytotoxicity.
Mulyana Y; Weber DK; Buck DP; Motti CA; Collins JG; Keene FR
Dalton Trans; 2011 Feb; 40(7):1510-23. PubMed ID: 21218244
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru(III) complexes.
Tan C; Liu J; Chen L; Shi S; Ji L
J Inorg Biochem; 2008 Aug; 102(8):1644-53. PubMed ID: 18468690
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of ruthenium(II)-arene PTA complexes.
Scolaro C; Bergamo A; Brescacin L; Delfino R; Cocchietto M; Laurenczy G; Geldbach TJ; Sava G; Dyson PJ
J Med Chem; 2005 Jun; 48(12):4161-71. PubMed ID: 15943488
[TBL] [Abstract][Full Text] [Related]
17. Arene ruthenium complexes as anticancer agents.
Süss-Fink G
Dalton Trans; 2010 Feb; 39(7):1673-88. PubMed ID: 20449402
[TBL] [Abstract][Full Text] [Related]
18. The contrasting chemistry and cancer cell cytotoxicity of bipyridine and bipyridinediol ruthenium(II) arene complexes.
Bugarcic T; Habtemariam A; Stepankova J; Heringova P; Kasparkova J; Deeth RJ; Johnstone RD; Prescimone A; Parkin A; Parsons S; Brabec V; Sadler PJ
Inorg Chem; 2008 Dec; 47(24):11470-86. PubMed ID: 19007206
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, anticancer and antibacterial activity of some novel mononuclear Ru(II) complexes.
Mazumder UK; Gupta M; Karki SS; Bhattacharya S; Rathinasamy S; Thangavel S
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):178-85. PubMed ID: 14758001
[TBL] [Abstract][Full Text] [Related]
20. Ruthenium(II)/(III) complexes of 4-hydroxy-pyridine-2,6-dicarboxylic acid with PPh3/AsPh3 as co-ligand: impact of oxidation state and co-ligands on anticancer activity in vitro.
Kamatchi TS; Chitrapriya N; Lee H; Fronczek CF; Fronczek FR; Natarajan K
Dalton Trans; 2012 Feb; 41(7):2066-77. PubMed ID: 22183160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
